...
首页> 外文期刊>Elektronika ir Elektrotechnika >In Silico Testing of the Semi-Closed Loop Infusion System with a New Simulator
【24h】

In Silico Testing of the Semi-Closed Loop Infusion System with a New Simulator

机译:使用新型模拟器对半闭环输液系统进行计算机测试

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Goal directed fluid therapy (GDFT) implies the flow-related parameters guided infusion of fluids. It requires adherence to complex clinical algorithms and fluid protocols, as well as simultaneous monitoring of several parameters and evaluation of their fluid responsiveness or actual response to fluid challenges. Automated clinical decision support systems (ACDSS) are used to ease the task. However, they are based on the flow-related (hemodynamic) parameters - arterial blood pressure, cardiac output, etc. Meanwhile, infusions guided by hemodynamic endpoints may lead to edema. A mini Volume Loading Test (mVLT) may be helpful in detection of imminent edema from changes in hemodilution during stepwise infusion which is conventionally used for hemodynamic optimization. We developed an ACDSS which is based on evaluation of both hemodynamic and hemodilution parameters. It operates on the basis of our unique algorithm which implies interchangeable application of fluid loading, vasopressor injection and red cell transfusion. This ACDSS is used in our PC-based command centre of a prototype semi-closed loop (SCL) infusion system. We developed a simulator - 'Virtual Patient' - on the basis of our previous clinical records aiming to test a new controller, as well as train the research team before starting a clinical trial. In silico testing continued for 12 hours on five occasions. Primary endpoint was the compliance of a controller with our clinical algorithm and the stability of operation in a spectrum of arterial hypotension and bleeding scenarios. The prototype SCL infusion system was found ready for clinical validation.
机译:目标导向的输液治疗(GDFT)暗示了与流量相关的参数指导输液。它需要遵守复杂的临床算法和输液方案,并同时监视多个参数并评估其对液体的反应性或对液体挑战的实际反应。自动化临床决策支持系统(ACDSS)用于简化任务。但是,它们是基于与流量相关的(血液动力学)参数-动脉血压,心输出量等。同时,以血液动力学终点为指导的输注可能导致水肿。迷你体积负荷测试(mVLT)可能有助于从逐步输注过程中血液稀释的变化中检测即将到来的水肿,这通常用于血液动力学优化。我们开发了基于血液动力学和血液稀释参数评估的ACDSS。它基于我们独特的算法进行操作,这意味着可互换地应用流体负荷,血管加压药注射和红细胞输注。该ACDSS在我们基于PC的半封闭环路(SCL)原型输注系统的命令中心中使用。我们根据以前的临床记录开发了一个模拟器-“虚拟患者”,旨在测试新的控制器,并在开始临床试验之前对研究团队进行培训。计算机模拟测试五次持续了12小时。主要终点是控制者对我们的临床算法的依从性以及在一系列动脉低血压和出血情况下的操作稳定性。发现原型SCL输液系统已准备好用于临床验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号